CONMED CNMD Cash Flow Statement
| Q1 '26 | Q4 '25 | Q3 '25 | Q2 '25 | Q1 '25 | ||
|---|---|---|---|---|---|---|
| $13.83M-17.4% | $16.74M+485% | $2.86M-86.7% | $21.42M+255% | $6.04M-82.1% | ||
| $4.17M+2.7% | $4.07M-7.1% | $4.38M-2.0% | $4.47M+5.5% | $4.24M+0.9% | ||
| $5.5M+10.7% | $4.97M+8.4% | $4.59M-6.5% | $4.9M-64.6% | $13.86M+123% | ||
| $1.54M+89.0% | $812K-78.0% | $3.69M+119% | $1.68M+163% | -$2.66M-140% | ||
| $1.28M-17.1% | $1.54M+20.6% | $1.28M-8.1% | $1.39M-3.8% | $1.44M-0.1% | ||
| -$18.61M-182% | $22.67M+347% | -$9.16M-217% | $7.84M+141% | -$18.98M-253% | ||
| $12.27M— | —— | $2.22M-60.1% | $5.55M-25.7% | $7.48M+3.9% | ||
| $10.48M+177% | -$13.61M-349% | $5.48M— | —— | -$7.32M— | ||
| -$21.15M-457% | $5.92M-26.5% | $8.06M-11.5% | $9.11M+211% | -$8.18M— | ||
| $17.22M+7,551% | $225K-92.6% | $3.06M-31.3% | $4.45M-17.9% | $5.42M+49.9% | ||
| -$2.76M-142% | $6.61M+69.2% | $3.91M+127% | -$14.37M-243% | $10.05M+298% | ||
| —— | -$139.5K0.0% | -$139.5K0.0% | -$139.5K0.0% | -$139.5K-189% | ||
| $722K-96.3% | $19.45M+1,350% | $1.34M+175% | -$1.8M-145% | $3.96M— | ||
| $13.47M-70.9% | $46.34M-13.7% | $53.69M+84.3% | $29.13M-29.9% | $41.53M-4.2% | ||
| $2.89M-43.4% | $5.11M-1.5% | $5.19M-9.5% | $5.73M+51.6% | $3.78M-6.5% | ||
| $0-100% | $2M— | —— | —— | -$850K— | ||
| $4.11M+158% | -$7.11M-37.1% | -$5.19M+9.5% | -$5.73M-95.6% | -$2.93M+27.5% | ||
| $0-100% | $6.19M0.0% | $6.19M0.0% | $6.19M+0.1% | $6.18M0.0% | ||
| $37.02M— | —— | —— | —— | $0— | ||
| $180M-3.7% | $187M+12.0% | $167M-4.8% | $175.43M+5.7% | $166M+10.7% | ||
| $0-100% | $20M-20.0% | $25M-37.9% | $40.23M+176% | $14.59M— | ||
| $828K+20,600% | $4K-97.3% | $147K-69.6% | $483K+204% | -$464K-326% | ||
| -$22.55M+39.6% | -$37.37M+14.1% | -$43.53M-64.1% | -$26.53M+6.6% | -$28.4M+44.4% | ||
| -$814K-2,494% | $34K+70.0% | $20K-98.7% | $1.57M+91.9% | $819K+137% | ||
| -$5.79M-407% | $1.89M-62.2% | $4.99M— | $0-100% | $11.03M— | ||
| —— | $6.35M0.0% | $6.35M0.0% | $6.35M0.0% | $6.35M-22.2% | ||
| $1.28M-17.1% | $1.54M+20.6% | $1.28M-8.1% | $1.39M-3.8% | $1.44M-0.1% | ||
| $722K-96.3% | $19.45M+1,350% | $1.34M+175% | -$1.8M-145% | $3.96M— | ||
| $4.17M+2.7% | $4.07M-7.1% | $4.38M-2.0% | $4.47M+5.5% | $4.24M+0.9% | ||
| -$3.92M— | —— | —— | —— | $0— | ||
| -$21.15M-457% | $5.92M-26.5% | $8.06M-11.5% | $9.11M+211% | -$8.18M— | ||
| $17.22M+7,551% | $225K-92.6% | $3.06M-31.3% | $4.45M-17.9% | $5.42M+49.9% | ||
| $14.66M-0.8% | $14.78M+3.9% | $14.23M+0.9% | $14.11M+0.6% | $14.02M+1.5% | ||
| $0-100% | $2M— | —— | —— | -$850K— | ||
| -$7M— | —— | —— | —— | $0— | ||
| $11.36M+1.6% | $11.18M+31.8% | $8.48M+22.4% | $6.93M-3.3% | $7.17M-18.5% | ||
| $828K+20,600% | $4K-97.3% | $147K-69.6% | $483K+204% | -$464K-326% | ||
| $0-100% | $20M-20.0% | $25M-37.9% | $40.23M+176% | $14.59M— | ||
| $10.58M-74.3% | $41.22M-15.0% | $48.5M+107% | $23.41M-38.0% | $37.76M-3.9% | ||
| $10.58M-74.3% | $41.22M-15.0% | $48.5M+107% | $23.41M-38.0% | $37.76M-3.9% |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- How much cash does CONMED generate?
- CONMED (CNMD) generated $142.6M in operating cash flow over the trailing twelve months.
- What is CONMED's free cash flow?
- After $18.9M of capital expenditures, CONMED's free cash flow was $123.7M over the trailing twelve months, down 24.8% year over year.
- Where does CONMED's cash flow data come from?
- Every line is extracted from CONMED's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.
